Ligand validation:4HYJ

LFA: EICOSANE

LFA is a Ligand Of Interest in 4HYJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
4HYJ_LFA_B_302	48%	74%	0.164	0.962	0.2	0.79	-	-	1	70%	0.7
4HYJ_LFA_B_310	43%	88%	0.095	0.923	0.26	0.41	-	-	0	40%	0.4
4HYJ_LFA_A_306	30%	82%	0.188	0.906	0.25	0.55	-	-	1	70%	0.7
4HYJ_LFA_B_311	25%	85%	0.146	0.891	0.26	0.48	-	-	0	40%	0.4
4HYJ_LFA_A_304	19%	78%	0.18	0.791	0.27	0.6	-	-	2	90%	0.9
4HYJ_LFA_A_311	19%	87%	0.204	0.886	0.27	0.43	-	-	1	50%	0.5
4HYJ_LFA_B_303	19%	85%	0.21	0.874	0.29	0.45	-	-	1	60%	0.6
4HYJ_LFA_B_315	18%	89%	0.201	0.897	0.28	0.35	-	-	0	40%	0.4
4HYJ_LFA_A_302	17%	82%	0.114	0.79	0.28	0.51	-	-	0	45%	0.45
4HYJ_LFA_B_312	16%	84%	0.162	0.842	0.27	0.48	-	-	0	40%	0.4
4HYJ_LFA_B_308	16%	77%	0.174	0.816	0.28	0.64	-	-	1	60%	0.6
4HYJ_LFA_B_307	16%	87%	0.144	0.8	0.31	0.39	-	-	1	50%	0.5
4HYJ_LFA_A_305	16%	75%	0.236	0.857	0.3	0.67	-	-	1	70%	0.7
4HYJ_LFA_A_308	15%	87%	0.152	0.804	0.3	0.39	-	-	1	50%	0.5
4HYJ_LFA_B_314	10%	81%	0.218	0.812	0.26	0.55	-	-	0	50%	0.5
4HYJ_LFA_A_303	9%	84%	0.24	0.821	0.27	0.48	-	-	0	50%	0.5
4HYJ_LFA_B_318	9%	84%	0.313	0.878	0.25	0.5	-	-	3	60%	0.6
4HYJ_LFA_B_309	9%	82%	0.213	0.753	0.3	0.49	-	-	0	70%	0.7
4HYJ_LFA_A_307	7%	83%	0.219	0.72	0.29	0.48	-	-	0	70%	0.7
4HYJ_LFA_B_304	4%	83%	0.196	0.675	0.27	0.51	-	-	0	50%	0.5
4HYJ_LFA_A_309	4%	87%	0.225	0.704	0.31	0.37	-	-	0	40%	0.4
4HYJ_LFA_A_312	4%	89%	0.261	0.746	0.26	0.37	-	-	0	30%	0.3
4HYJ_LFA_B_306	3%	85%	0.293	0.749	0.26	0.48	-	-	0	40%	0.4
4HYJ_LFA_B_313	3%	87%	0.22	0.648	0.28	0.41	-	-	0	40%	0.4
4HYJ_LFA_B_305	2%	85%	0.219	0.591	0.29	0.45	-	-	1	60%	0.6
4HYJ_LFA_A_310	2%	87%	0.256	0.598	0.28	0.42	-	-	0	50%	0.5
4HYJ_LFA_B_317	1%	88%	0.294	0.639	0.24	0.42	-	-	0	30%	0.3
4HYJ_LFA_B_316	1%	90%	0.23	0.542	0.24	0.38	-	-	1	30%	0.3
4HYJ_LFA_B_319	0%	87%	0.368	0.434	0.31	0.39	-	-	1	40%	0.4
4HYJ_LFA_A_313	0%	91%	0.332	0.358	0.3	0.26	-	-	0	30%	0.3
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	75%	0.75
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	55%	0.55
8R98_LFA_A_401	55%	100%	0.089	0.937	0.09	0.08	-	-	0	55%	0.55
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	70%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.

Prepare Data

Validate Data

Deposit Data

Help and Resources

4HYJ

LFA: EICOSANE

LFA is a Ligand Of Interest in 4HYJ designated by the RCSB